Rivamo combines advanced proprietary technology with deep operational expertise to power successful government-led cannabis research initiatives. Our capabilities ensure full compliance, seamless project execution, and meaningful public health impact.
Rivamo operates Switzerland’s largest government-backed cannabis research project, in partnership with ETH Zurich, the University of Zurich and the Swiss Federal Office of Public Health (FOPH).
With 7,500 enrolled participants and 5,000 active users, the project provides robust data to inform evidence-based cannabis regulation and public health policy.
Rivamo’s proprietary technology ensures full legal compliance, advanced track & trace, participant management and comprehensive data reporting.
Collaborating with government bodies and academic partners to define research scope and ensure full regulatory compliance.
Managing participant enrollment, loyalty programs and user experience through a secure, customizable platform.
Ensuring full legal traceability, product validation and multi-channel distribution through pharmacies, dispensaries and home delivery.
Collecting and analyzing high-quality data to support research objectives and inform public policy.
Providing governments and researchers with actionable insights to guide evidence-based cannabis policy development.
Discuss your cannabis policy and research needs with our experts. Tailored solutions for government partners.
Leverage Rivamo’s proven expertise, proprietary technology and trusted partnerships to power your legal cannabis research initiatives.
Building trusted partnerships and powering Europe’s legal cannabis industry with proprietary technology and Swiss expertise
© 2025 Rivamo SA. All rights reserved.